🔗 Share this article

This year's prestigious award in Physiology or Medicine was awarded for revolutionary findings that clarify how the immune system targets harmful infections while protecting the body's own cells.

A trio of esteemed researchers—from Japan Shimon Sakaguchi and US experts Mary Brunkow and Dr. Ramsdell—share this accolade.

The work uncovered unique "security guards" within the immune system that remove rogue defense cells that could harming the organism.

The findings are now paving the way for innovative treatments for autoimmune diseases and malignancies.

These laureates will share a monetary award worth 11 million SEK.

Crucial Discoveries

"The research has been essential for comprehending how the body's defenses functions and why we don't all suffer from severe autoimmune diseases," commented the head of the Nobel Committee.

The team's research address a fundamental question: In what way does the immune system defend us from countless invaders while keeping our own tissues unharmed?

The immune system employs white blood cells that scan for signs of infection, including pathogens and germs it has not met before.

Such defenders employ sensors—known as receptors—that are generated by chance in a vast number of variations.

That provides the immune system the ability to fight a wide array of threats, but the randomness of the mechanism unavoidably produces white blood cells that can attack the body.

Protectors of the Immune System

Researchers previously knew that some of these harmful defense cells were eliminated in the immune organ—the site where immune cells develop.

This year's Nobel Prize honors the discovery of T-reg cells—known as the body's "security guards"—which travel through the system to disarm other defenders that assault the body's own tissues.

We know that this process malfunctions in autoimmune diseases such as juvenile diabetes, MS, and RA.

A Nobel panel added, "The discoveries have established a new field of investigation and spurred the creation of new therapies, for instance for cancer and autoimmune diseases."

Regarding malignancies, T-regs prevent the body from attacking the growth, so studies are aimed at lowering their quantity.

For self-attack disorders, trials are testing boosting T-reg cells so the organism is not being harmed. A comparable method could also be effective in reducing the risks of transplanted organ failure.

Innovative Studies

Professor Sakaguchi, from a Japanese institution, performed experiments on mice that had their thymus extracted, leading to self-attack conditions.

He showed that injecting immune cells from other animals could prevent the illness—implying there was a system for blocking defenders from attacking the body.

Mary Brunkow, affiliated with the a research center in Seattle, and Dr. Ramsdell, currently at Sonoma Biotherapeutics in San Francisco, were investigating an inherited immune disorder in mice and humans that led to the discovery of a gene critical for how T-regs operate.

"Their groundbreaking research has revealed how the immune system is kept in check by regulatory T cells, stopping it from accidentally attacking the body's own tissues," said a prominent physiology specialist.

"The work is a striking illustration of how fundamental biological research can have broad consequences for human health."